Avanos Medical Inc(AVNS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -1.61 | Insider Own | 2.77% | Shs Outstand | 46.7M | Perf Week | - |
| Market Cap | 1.17B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 46.3M | Perf Month | 0.28% |
| Enterprise Value | 1.24B | PEG | - | EPS next Q | - | Inst Own | 90.31% | Short Float | 3.78% | Perf Quarter | 1.09% |
| Income | -0.07B | P/S | 1.64 | EPS this Y | - | Inst Trans | -7.39% | Short Ratio | 1.6 | Perf Half Y | 79.78% |
| Sales | 0.72B | P/B | 1.49 | EPS next 5Y | - | ROA | -6.9% | Short Interest | 1.75M | Perf YTD | 122.53% |
| Book/sh | 16.76 | P/C | 17.85 | EPS past 3/5Y | - -22.58% | ROE | -9.18% | 52W High | -1.96% ($25.49) | Perf Year | 110.35% |
| Cash/sh | 1.4 | P/FCF | 156.1 | Sales past 3/5Y | 0.83% -0.38% | ROIC | -8.27% | 52W Low | 168.62% ($9.30) | Perf 3Y | -2.15% |
| Dividend Est. | - | EV/EBITDA | 16.74 | EPS Y/Y TTM | 80.78% | Gross Margin | 48.55% | Volatility(W/M) | 0.07% 0.22% | Perf 5Y | -28.09% |
| Dividend TTM | - | EV/Sales | 1.74 | Sales Y/Y TTM | 3.87% | Oper. Margin | 4.86% | ATR (14) | 0.06 | Perf 10Y | -25.51% |
| Dividend Ex-Date | - | Quick Ratio | 1.4 | EPS Q/Q | -23.83% | Profit Margin | -10.39% | RSI (14) | 62.11 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.48 | Sales Q/Q | 8.78% | SMA20 | 0.23% ($24.93) | Beta | 1.58 | Target Price | $14 |
| Payout | - | Debt/Eq | 0.18 | Earnings | 2026/5/5 | SMA50 | 0.37% ($24.9) | Rel Volume | 0 | Prev Close | $24.99 |
| Employees | 2287 | LT Debt/Eq | 0.15 | EPS/Sales Surpr. | 57.14% 7.18% | SMA200 | 47.72% ($16.92) | Avg Volume(3M) | 1.10M | Price | $24.99 |
| IPO | 2014/10/21 | Option/Short | Yes/No | Trades | 0 | Volume | - | Change | - |
Company
AVNS is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
Avanos Medical (AVNS) is a U.S. medical device company focused on digestive health and pain management and recovery. It was spun off from Kimberly-Clark in 2014 and listed independently, supplying enteral feeding tubes, surgical pain pumps, and cold and compression therapy systems to healthcare facilities worldwide. With demand driven primarily by consumable and single-use medical devices, it is a small- to mid-cap healthcare stock with a stable demand base.
Over the past 1 year, on the higher side
2% below its 1-year high.
AVNS has weak earning power
4.86% of revenue is kept as operating profit.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 2 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Would have changed by -2.1% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 90.3%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
MRGR 0.02%
EVNT 0.02%
XHE 0.02%
TSME 0.01%
ARB 0.01%It ranks #4 in the industry
Based on market cap of $1B.
AVNS $1B PER -
ABT $178B PER 33.3
MDT $120B PER 23.1
SYK $108B PER 29.2
FAQ
What kind of company is AVNS?
AVNS belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of AVNS?
The market cap of AVNS is approximately $1.2B, ranking 2,560 within its sector.
What is the 52-week high and low for AVNS?
AVNS has recorded a 52-week high of $25.49 and a low of $9.30.
